Hydroxyzine Bluefish

Hydroxyzine hydrochloride, the active ingredient in Hydroxyzine Bluefish, is a first‑generation antihistamine presented as an oral tablet for oral administration. It is used to alleviate allergic skin conditions, reduce pruritus, provide anxiolytic effects, facilitate pre‑operative sedation and control nausea in adult patients.

GNH USA supplies Hydroxyzine Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product is manufactured in the European Union and meets EU pharmacopeial standards. It is distributed under a valid marketing authorization and complies with international quality guidelines.

Hydroxyzine works by blocking H1 histamine receptors, providing relief across several allergic and anxiety‑related conditions.

Allergic skin conditions: reduces itching and inflammation associated with allergic dermatitis. Pruritus: alleviates intense itching caused by dermatologic disorders. Anxiety: produces calming effects useful in short‑term management of anxiety. Pre‑operative sedation: induces sedation to facilitate surgical procedures. Nausea: helps control nausea and vomiting in various clinical settings.

Hydroxyzine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Dry mouth: decreased salivation leading to a sticky sensation. - Blurred vision: temporary difficulty focusing. - Constipation: reduced bowel movements. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects: - Tachycardia: rapid heart rate that may require medical attention. - Severe hypotension: marked drop in blood pressure causing faintness. - Allergic reactions: rash, swelling, or anaphylaxis. - Seizures: convulsive episodes in susceptible individuals. - Arrhythmias: irregular heart rhythms.

When prescribing hydroxyzine, clinicians should consider several safety precautions.

Pregnancy: Category B; use only if benefit outweighs risk. Elderly patients: increased sensitivity to sedative and anticholinergic effects; monitor closely. Driving and machinery: avoid operating vehicles or heavy equipment until individual response is known. Concomitant CNS depressants: assess risk of additive sedation when combined with alcohol, opioids or benzodiazepines. Store at ambient temperature: keep in original container, protect from moisture and light.

Hydroxyzine can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe hypotension and additive CNS depression. - CNS depressants (benzodiazepines, opioids, barbiturates): may cause profound sedation and respiratory depression. - Alcohol: enhances sedative effects and impairs coordination.

Moderate Interactions (Monitor Closely): - Anticholinergic drugs (e.g., atropine, antihistamines): may increase dryness, constipation and urinary retention. - Antihypertensive agents: hydroxyzine may potentiate blood pressure‑lowering effects. - Tricyclic antidepressants: combined anticholinergic load can intensify side effects.